You really don't believe in any payout, do you?5 years of price declines, finally some recovery and sale at 31c, just before publishing half year report. What a poor joke.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%